The global meningitis treatment market is positioned for consistent growth over the next decade, driven by rising awareness of the disease, improvements in healthcare infrastructure, and advancements in treatment options. According to recent market insights, the market is expected to grow at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2032. Valued …